These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24698342)

  • 1. Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice.
    Terzian AL; Micale V; Wotjak CT
    Eur J Neurosci; 2014 Jul; 40(1):2293-8. PubMed ID: 24698342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors.
    Martín-García E; Bourgoin L; Cathala A; Kasanetz F; Mondesir M; Gutiérrez-Rodriguez A; Reguero L; Fiancette JF; Grandes P; Spampinato U; Maldonado R; Piazza PV; Marsicano G; Deroche-Gamonet V
    Neuropsychopharmacology; 2016 Aug; 41(9):2192-205. PubMed ID: 26612422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission.
    Jacob W; Yassouridis A; Marsicano G; Monory K; Lutz B; Wotjak CT
    Genes Brain Behav; 2009 Oct; 8(7):685-98. PubMed ID: 19563475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration.
    Häring M; Kaiser N; Monory K; Lutz B
    PLoS One; 2011; 6(11):e26617. PubMed ID: 22069458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus.
    Steindel F; Lerner R; Häring M; Ruehle S; Marsicano G; Lutz B; Monory K
    J Neurochem; 2013 Mar; 124(6):795-807. PubMed ID: 23289830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB₁ receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations.
    Häring M; Grieb M; Monory K; Lutz B; Moreira FA
    Neuropharmacology; 2013 Feb; 65():83-9. PubMed ID: 23000076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
    Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A restricted population of CB1 cannabinoid receptors with neuroprotective activity.
    Chiarlone A; Bellocchio L; Blázquez C; Resel E; Soria-Gómez E; Cannich A; Ferrero JJ; Sagredo O; Benito C; Romero J; Sánchez-Prieto J; Lutz B; Fernández-Ruiz J; Galve-Roperh I; Guzmán M
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8257-62. PubMed ID: 24843137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type-specific genetic reconstitution of CB1 receptor subsets to assess their role in exploratory behaviour, sociability, and memory.
    De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F
    Eur J Neurosci; 2022 Feb; 55(4):939-951. PubMed ID: 33253450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder function in a cannabinoid receptor type 1 knockout mouse.
    Füllhase C; Campeau L; Sibaev A; Storr M; Hennenberg M; Gratzke C; Stief C; Hedlund P; Andersson KE
    BJU Int; 2014 Jan; 113(1):144-51. PubMed ID: 24053792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons.
    Albayram Ö; Passlick S; Bilkei-Gorzo A; Zimmer A; Steinhäuser C
    Pflugers Arch; 2016 Apr; 468(4):727-37. PubMed ID: 26739712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations.
    Ortega-Álvaro A; Navarrete F; Aracil-Fernández A; Navarro D; Berbel P; Manzanares J
    Neuropsychopharmacology; 2015 Oct; 40(11):2639-47. PubMed ID: 25895455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Serotonin 2C Receptors with SB-242084 Moderates Reduced Locomotor Activity and Rearing by Cannabinoid 1 Receptor Antagonist AM-251.
    Bogáthy E; Kostyalik D; Petschner P; Vas S; Bagdy G
    Pharmacology; 2019; 103(3-4):151-158. PubMed ID: 30673678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance.
    Dubreucq S; Durand A; Matias I; Bénard G; Richard E; Soria-Gomez E; Glangetas C; Groc L; Wadleigh A; Massa F; Bartsch D; Marsicano G; Georges F; Chaouloff F
    Biol Psychiatry; 2013 May; 73(9):895-903. PubMed ID: 23237313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
    Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
    Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses.
    Steiner MA; Marsicano G; Wotjak CT; Lutz B
    Psychoneuroendocrinology; 2008 Sep; 33(8):1165-70. PubMed ID: 18653287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB
    Saravia R; Flores Á; Plaza-Zabala A; Busquets-Garcia A; Pastor A; de la Torre R; Di Marzo V; Marsicano G; Ozaita A; Maldonado R; Berrendero F
    Biol Psychiatry; 2017 Apr; 81(7):625-634. PubMed ID: 27737762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.
    Rey AA; Purrio M; Viveros MP; Lutz B
    Neuropsychopharmacology; 2012 Nov; 37(12):2624-34. PubMed ID: 22850737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.
    Haller J; Bakos N; Szirmay M; Ledent C; Freund TF
    Eur J Neurosci; 2002 Oct; 16(7):1395-8. PubMed ID: 12405999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
    Musella A; Sepman H; Mandolesi G; Gentile A; Fresegna D; Haji N; Conrad A; Lutz B; Maccarrone M; Centonze D
    Neuropharmacology; 2014 Apr; 79():567-72. PubMed ID: 24440366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.